Philip O’Connell is a clinical professor in medicine at the University of Sydney. He is director of Transplantation and medical director of the National Pancreas Transplant Unit, Westmead Hospital. Currently he is director of the Centre for Transplant and Renal Research, The Westmead Institute of Medical Research. His major research interests are in the development of islet transplantation as a main stream treatment for type 1 diabetes and the use of genomics as a marker of renal allograft dysfunction. He was a principle investigator of the NIH funded GOCAR study. He is director of the Australian Clinical Islet Transplant Consortium, which has undertaken Australia’s first multicentre clinical trial of islet transplantation. Currently, he is past-president of The Transplantation Society and a member of the executive of the Declaration of Istanbul Custodian Group.
14:45 - 16:15
|State-of-the-Art Session — Recurrent Liver Allograft Disease: How to Deal With (Videos Available)||N-101|
14:30 - 16:00
|State-of-the-Art Session — Joint TTS-AST-ASTS-ESOT: Advancing Transplant Therapeutics and Innovation (Videos Available)||N-115/116|
08:30 - 09:30
|Morning Symposium — Tackling the Challenges Posed by Donor Intervention Research (Videos Available)||N-115/116|
|Scientific Program Committee||Chair|